BR112022025132A2 - Formulações de diclofenaco à base de açúcar biodisponíveis - Google Patents

Formulações de diclofenaco à base de açúcar biodisponíveis

Info

Publication number
BR112022025132A2
BR112022025132A2 BR112022025132A BR112022025132A BR112022025132A2 BR 112022025132 A2 BR112022025132 A2 BR 112022025132A2 BR 112022025132 A BR112022025132 A BR 112022025132A BR 112022025132 A BR112022025132 A BR 112022025132A BR 112022025132 A2 BR112022025132 A2 BR 112022025132A2
Authority
BR
Brazil
Prior art keywords
bioavailable
sugar
diclofenac
formulations
diclofenac formulations
Prior art date
Application number
BR112022025132A
Other languages
English (en)
Inventor
Reiner Alberto
Reiner Giorgio
Original Assignee
Applied Pharma Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Pharma Res filed Critical Applied Pharma Res
Publication of BR112022025132A2 publication Critical patent/BR112022025132A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/534—Mentha (mint)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

FORMULAÇÕES DE DICLOFENACO À BASE DE AÇÚCAR BIODISPONÍVEIS. São reveladas formulações líquidas prontas para uso de diclofenaco potássio, que são particularmente bem adequadas para embalagens em pacotes de bastão.
BR112022025132A 2020-06-10 2021-06-08 Formulações de diclofenaco à base de açúcar biodisponíveis BR112022025132A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202063037483P 2020-06-10 2020-06-10
PCT/IB2021/055041 WO2021250571A1 (en) 2020-06-10 2021-06-08 Bioavailable sugar-based diclofenac formulations

Publications (1)

Publication Number Publication Date
BR112022025132A2 true BR112022025132A2 (pt) 2022-12-27

Family

ID=76807916

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112022025132A BR112022025132A2 (pt) 2020-06-10 2021-06-08 Formulações de diclofenaco à base de açúcar biodisponíveis

Country Status (9)

Country Link
US (1) US20230233494A1 (pt)
EP (1) EP4164612A1 (pt)
KR (1) KR20230022941A (pt)
CN (1) CN115768406A (pt)
AU (1) AU2021286957A1 (pt)
BR (1) BR112022025132A2 (pt)
CA (1) CA3180560A1 (pt)
IL (1) IL298861A (pt)
WO (1) WO2021250571A1 (pt)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1234194B (it) * 1988-05-31 1992-05-06 Magis Farmaceutici Composizioni farmaceutiche in forma di sciroppo contenenti pentitoli quali agenti di veicolazione
IT1283029B1 (it) 1996-05-17 1998-04-03 Resa Farma Composizioni farmaceutiche a base di diclofenac
ES2199916T3 (es) 2001-11-20 2004-03-01 Apr Applied Pharma Research S.A. Composiciones farmaceuticas hidrosolubles no efervescentes que comprenden farmacos antiinflamatorios no esteroideos.
ATE344193T1 (de) 2002-02-08 2006-11-15 Procter & Gamble Kindersichere verpackung
ITMI20022271A1 (it) * 2002-10-25 2004-04-26 Farmaka Srl Composizioni farmaceutiche bioadesive a base di anitiinfiammatori non steroidei.
JO3352B1 (ar) 2005-06-17 2019-03-13 Apr Applied Pharma Res Sa صيغ دايكلوفيناك وطرق استخدامه
CN105793168A (zh) 2013-11-27 2016-07-20 强生消费者公司 棒装小袋包装
US11260026B2 (en) * 2018-12-14 2022-03-01 Apr Applied Pharma Research Sa Ready to use diclofenac stick packs

Also Published As

Publication number Publication date
US20230233494A1 (en) 2023-07-27
WO2021250571A1 (en) 2021-12-16
IL298861A (en) 2023-02-01
CA3180560A1 (en) 2021-12-16
AU2021286957A1 (en) 2023-02-09
KR20230022941A (ko) 2023-02-16
EP4164612A1 (en) 2023-04-19
CN115768406A (zh) 2023-03-07

Similar Documents

Publication Publication Date Title
CO2019002239A2 (es) Formulaciones, kits y métodos de anticuerpos inhibidores de masp-2 de baja viscosidad altamente concentrados
UY38001A (es) Compuestos que inhiben las proteínas ras mutantes g12c
CO2019009258A2 (es) Administración rápida y controlada de composiciones con efectos séquito restaurados
BR112019002042A2 (pt) ajuste dinâmico de fusão
CR20140185A (es) Derivados de (4-fenilimidazol-2-il)etilamina útiles como moduladores de canal de sodio
DOP2010000191A (es) Derivados bis-(sulfonilamino)
CL2016001367A1 (es) Gamma-dicetonas como activadores de la ruta de señalización de wnt/beta-catenina (divisional de solicitud n° 2363-2015).
DOP2014000123A (es) Composiciones intranasales de dexmedetomidina y métodos de uso de ellas
ECSP10010167A (es) Composiciones oftálmicas novedosas
AR089342A1 (es) Sistema que provee una reaccion catalizada por perhidrolasas
CR20150560A (es) Formas cristalinas de inhibidores de tirosina cinasa y sus sales
CL2012003104A1 (es) Compuestos derivados de multiheteroarilos, inhibidores de prostaglandina d sintasa hematopoyetica (h-pgds); y composicion farmaceutica que los comprende.
CL2018000688A1 (es) Compuestos heterociclicos que contienen bencilamina y composiciones útiles contra infección por micobacterias
BR112013000399A2 (pt) método para a esterilização de pelo menos um objeto, aparelho de esterilização e seu uso
CL2018000621A1 (es) Ciano tienotriazolpirazinas y usos de las mismas solicitudes relacionadas.
CL2019001337A1 (es) Formulaciones farmacéuticas.
CL2013000488A1 (es) Co-cristales de compuestos derivados de (2r)-5-oxo-1-(bencilpiperidin-4-il)-n-(piridin-2-il)pirrolidin-2-carboxamida y un agente de formacion de co-cristales; sales de los compuestos; compuestos intermediarios; composicion farmaceutica; y su uso para el tratamiento de enfermedades inflamatorias e infecciosas.
CL2011002675A1 (es) Uso de compuestos derivados de nitrato o sulfato de 9-purin-9-il-3,4-dihidroxitetrahidrofuran-2-il-metilo para reducir la presion intraocular ; composicion farmaceutica oftalmica que comprende los compuestos; y formulacion oftalmica de uso topico que los comprende.
AR103852A1 (es) DsbA Y DsbC ULTRAPURIFICADOS Y SUS MÉTODOS DE PREPARACIÓN Y USO
CO2021010930A2 (es) Hidroxipiridoxazepinas como activadores de nrf2
UY31788A (es) Formulación farmacéutica sólida con liberación retardada
BR112013026675A2 (pt) composições detergentes contendo mananase de bacillus sp., e métodos de uso das mesmas
BR112016017776A2 (pt) Formas sólidas de 2-(terc-butilamino)-4-((1r,3r,4r)-3-hidróxi-4-metil-ciclo-hexilamino)-pirimidina-5-carboxamida, composições das mesmas e métodos para seu uso
BR112023003106A2 (pt) Forma amorfa de um inibidor de malt1 e formulações do mesmo
UY37191A (es) Derivados de dibenzofurano para uso como inhibidores de bromodominio

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]